https://www.selleckchem.com/pr....oducts/chaetocin.htm
This was a European, multicenter, investigator-initiated and run, single-arm retrospective analysis to assess the safety and the clinical benefit of the use of paclitaxel-coated balloon (PC for the treatment of symptomatic central venous stenosis (CVS). Eleven centers from 7 countries across Europe, submitted 86 cases performed during the period between October 2015 and June 2018. Minimum follow-up was 6 months. Patient baseline demographics and procedural details were collected. Mean age was 62.6 years (SD 15.2 years). Median vascu
Me gusta
Comentario
Compartir
